drugset / Trial / NCT04421274

Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction

NCT04421274

RandomizedParallel-groupSingle-blindTreatment

Summary

To investigate the effect and safety of intracoronary autologous bone morrow mesenchymal stem cells (BM-MSCs) transplantation in patients with ST-segment elevation myocardial infarction( STEMI) .

Timeline

Start
2008-05-01
Primary completion
2010-07-10
Completion
2011-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Bone marrow mesenchymal stem cells Cell therapy Other

Indications